Dude, AVH's excuse is that "The reprioritization of hospital resources to support COVID-19 readiness meant that our April results were the lowest monthly revenue and procedural volumes seen this calendar year. " PNV no doubt would have had to deal with the same issue... yet ends the quarter with sales 33% higher than the previous quarter. AVH ends up with no QoQ growth.
"If PNV was so impressive, why have they fallen from above $2.80 down to almost $2.20 in a month?"
If you want to compare share price performance of AVH vs PNV from before the start of COVID through to now, let's take a look. Here is the year to date share price performance in a chart:
PNV is up 15.6% for the year while AVH is down 47.66%. So yeah, one business has certainly been doing a better job at selling products and attracting investors... all without the window dressing of a Nasdaq listing.
Given you own both stocks, I would have thought this had been clear to you, but maybe the picture above will help.
AVH on NASDAQ, page-309
-
- There are more pages in this discussion • 635 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.80 |
Change
0.120(4.48%) |
Mkt cap ! $193.9M | |||
| Open | High | Low | Value | Volume |
| $2.78 | $2.86 | $2.77 | $457.2K | 163.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4531 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |